For the Inventor, By the Inventor

Enter assignee name

Culver City, CA, United States of America

Indi Molecular, Inc.

USPTO Granted Patents = 13

EPO Patents = 5

Trademarks = 4

Forward Citations = 62

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Heather Dawn Agnew (11 out of 18 patents)

James R Heath (8 out of 56 patents)

Blake Farrow (5 out of 8 patents)

4. Suresh Mark Pitram (5 out of 5 patents)

5. Arundhati Nag (4 out of 14 patents)

6. Samir Das (4 out of 12 patents)

7. Paul Edward Kearney (4 out of 23 patents)

8. Bert Tsunyin Lai (4 out of 9 patents)

9. Rosemary Dyane Rohde (2 out of 6 patents)

10. Kaycie Deyle (2 out of 3 patents)

11. David Bunck (2 out of 4 patents)

12. Jingxin Liang (2 out of 7 patents)

13. Steven Wesley Millward (2 out of 5 patents)

14. Tsun Yin Lai (2 out of 2 patents)

15. Anders Eliasen (2 out of 5 patents)

13 patents: Sort by Forward Citations

1. 11766414 - Compositions, delivery systems, and methods useful in tumor therapy (2023-09-26),

2. 11733246 - Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1) (2023-08-22),

3. 11723944 - Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making (2023-08-15),

4. 11719705 - IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making (2023-08-08),

5. 11638764 - Theranostic capture agents, compositions, and methods of using and making (2023-05-02),

6. 11007245 - Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making (2021-05-18),

7. 10598671 - IL-17F-specific capture agents, compositions, and methods of using and making (2020-03-24),

8. 10221214 - Akt-specific capture agents, compositions, and methods of using and making (2019-03-05),

9. 9913875 - Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making (2018-03-13),

10. 9239332 - Akt-specific capture agents, compositions, and methods of using and making (2016-01-19),

11. 9221889 - VEGF-specific capture agents, compositions, and methods of using and making (2015-12-29),

12. 8841083 - PSA capture agents, compositions, methods and preparation thereof (2014-09-23),

13. 8710180 - VEGF-specific capture agents, compositions, and methods of using and making (2014-04-29),

Company Overview

Indi Molecular, Inc. is a biotechnology company based in Culver City, California, specializing in the development of innovative molecular solutions for therapeutic applications. The company focuses on leveraging advanced technologies to create novel drug delivery systems and enhance the efficacy of therapeutic agents. With a commitment to addressing unmet medical needs, Indi Molecular aims to transform the landscape of treatment options through its cutting-edge research and development efforts in the biopharmaceutical sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#30 in Culver City, CA

#5,656 in California

#23,838 in US

#45,039 in the World

Culver City, CA, United States of America

Indi Molecular, Inc.

Forward Citations = 62

17 inventors:

Heather Dawn Agnew (11 out of 18 patents)

James R Heath (8 out of 56 patents)

Blake Farrow (5 out of 8 patents)

4. Suresh Mark Pitram (5 out of 5 patents)

5. Arundhati Nag (4 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Indi Molecular, Inc.. Retrieved from https://idiyas.com/company/indi-molecular

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…